Masaki Kaibori Selected Research

Masaki Kaibori Research Topics

Disease

55	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 03/2003
38	Neoplasms (Cancer) 09/2022 - 07/2002
11	Fibrosis (Cirrhosis) 03/2016 - 07/2002
10	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 07/2002
10	Inflammation (Inflammations) 06/2022 - 07/2007
10	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2009
10	Liver Diseases (Liver Disease) 10/2021 - 07/2002
10	Wounds and Injuries (Trauma) 09/2021 - 02/2008
6	Infections 08/2021 - 01/2005
6	Liver Failure 11/2011 - 09/2006
5	Cholangiocarcinoma 02/2022 - 11/2012
5	Ischemia 10/2021 - 08/2006
5	Acute Liver Failure (Fulminant Hepatic Failure) 10/2019 - 02/2008
4	Carcinoma (Carcinomatosis) 09/2022 - 10/2010
4	Reperfusion Injury 10/2021 - 02/2008
3	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 11/2018
3	Pain (Aches) 01/2022 - 07/2015
3	Sepsis (Septicemia) 01/2022 - 07/2011
3	Stomach Neoplasms (Stomach Cancer) 01/2019 - 10/2014
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2016 - 11/2008
3	Hypertension (High Blood Pressure) 07/2015 - 11/2010
2	Fatigue 06/2022 - 07/2015
2	Diarrhea 06/2022 - 07/2015
2	Insulin Resistance 05/2022 - 08/2013
2	Lymphatic Metastasis 03/2022 - 04/2017
2	Hypoxia (Hypoxemia) 01/2022 - 04/2004
2	Diabetes Mellitus 09/2021 - 07/2015
2	Necrosis 01/2020 - 01/2019
2	Obesity 01/2019 - 05/2005
2	Postoperative Pain 07/2015 - 06/2012
2	Ulcerative Colitis 09/2014 - 01/2010
2	Thrombosis (Thrombus) 11/2012 - 11/2010
2	Colonic Neoplasms (Colon Cancer) 11/2012 - 09/2005
2	Endotoxemia 01/2005 - 11/2004
1	Hemorrhage 08/2022

Drug/Important Bio-Agent (IBA)

9	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 11/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 08/2006
8	CytokinesIBA 10/2019 - 07/2002
7	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 03/2003
7	Proteins (Proteins, Gene)FDA Link 04/2015 - 08/2006
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 07/2002
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022 - 07/2004
5	AlbuminsIBA 04/2022 - 11/2008
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2010
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 08/2006
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 09/2014
4	Serum AlbuminIBA 01/2021 - 02/2013
4	AcidsIBA 06/2020 - 06/2014
4	acarboxyprothrombin (PIVKA)IBA 01/2016 - 07/2004
4	Vitamin K FDA Link 10/2010 - 04/2007
3	Bevacizumab (Avastin)FDA Link 10/2022 - 06/2022
3	atezolizumabIBA 10/2022 - 06/2022
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 01/2017
3	lenvatinibIBA 06/2022 - 12/2021
3	Pharmaceutical PreparationsIBA 01/2022 - 09/2014
3	NF-kappa B (NF-kB)IBA 10/2019 - 02/2008
3	EdaravoneIBA 12/2008 - 01/2005
2	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 01/2014
2	BilirubinIBA 04/2022 - 11/2010
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 11/2021 - 05/2021
2	Active Hexose Correlated CompoundIBA 11/2019 - 08/2014
2	ChemokinesIBA 10/2019 - 03/2008
2	Antineoplastic Agents (Antineoplastics)IBA 09/2019 - 01/2017
2	Therapeutic UsesIBA 09/2019 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2005
2	InterleukinsIBA 01/2019 - 08/2006
2	OligonucleotidesIBA 01/2018 - 04/2013
2	Fluvastatin FDA Link 09/2014 - 07/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013 - 02/2008
2	AntibodiesIBA 06/2012 - 05/2003
2	Secretory Proteinase Inhibitory ProteinsIBA 06/2011 - 03/2008
2	Free Radical ScavengersIBA 12/2008 - 01/2005
2	GalactosamineIBA 06/2008 - 03/2008
2	Interleukin-1beta (Interleukin 1 beta)IBA 07/2007 - 07/2002
2	MucinsIBA 01/2007 - 09/2005
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2007 - 09/2005
2	pro-hepatocyte growth factorIBA 01/2006 - 07/2002
2	salicylhydroxamic acid (SHAM)IBA 07/2002 - 07/2002
1	C-Reactive ProteinIBA 10/2022
1	Photosensitizing Agents (Photosensitizers)IBA 09/2022

Therapy/Procedure

39	Hepatectomy 01/2022 - 07/2002
16	Therapeutics 09/2022 - 07/2002
12	Drug Therapy (Chemotherapy) 06/2022 - 11/2010
5	Blood Transfusion (Blood Transfusions) 01/2018 - 04/2007
5	Liver Transplantation 06/2014 - 05/2005
4	Segmental Mastectomy (Lumpectomy) 07/2022 - 11/2012
4	Neoadjuvant Therapy 01/2022 - 12/2009
4	Kampo Medicine (Kampo) 01/2020 - 01/2012
4	Gastrectomy 01/2019 - 10/2014
3	Aftercare (After-Treatment) 06/2022 - 01/2016
3	Sutures (Suture) 01/2022 - 08/2016
3	Adjuvant Chemotherapy 01/2022 - 07/2007
3	Photochemotherapy (Photodynamic Therapy) 01/2021 - 01/2017
3	Length of Stay 01/2015 - 01/2014
2	Exercise Therapy (Therapy, Exercise) 05/2022 - 08/2013
2	Transplantation 11/2019 - 11/2006
2	Radiofrequency Ablation 01/2016 - 07/2015
2	Contraindications 12/2009 - 11/2008
1	Immunotherapy 10/2022